BOSTON -- Harvard Medical School researchers have uncovered a missing link in our understanding of how human papillomaviruses gain their foothold in the rapidly dividing cells of the skin and mucous membranes. The discovery, reported in the April 30 Cell, could lead to new treatments for a host of human papillomavirus-related conditions, from the nuisance of plantar and genital warts to life-threatening precancerous cervical lesions.

"We have uncovered a new target that could potentially lead to new antivirals. There is certainly a need because there are no specific human papillomavirus antivirals out there at this point," said Peter Howley, the Shattuck professor of pathological anatomy at HMS.

Unlike some virusessuch as influenza, HIV, and the common cold viruswhich churn out copies within the confines of a single host cell that is then destroyed, human papillomaviruses invade proliferating epithelial cells and distribute their copies among subsequent generations. To maintain their integrity, and to ensure that the viral DNA is properly partitioned between daughter cells, human papillomaviruses have adopted the strategy of tying their genetic material, via the viral protein E2, to a protein found on the host's mitotic chromosomes. But the identity of that chromosomal protein has been elusive.

Howley, Jianxin You, HMS research fellow in pathology, and their colleagues have identified the missing chromosomal link in cells infected with a bovine form of papillomavirus. By blocking the protein, BRD4, they prevented papillomavirus-infected mouse cells from becoming cancerous. Perhaps most significant, BRD4 appears to tether human papillomavirus as well.

"This suggests that if one could come up with a small molecule or chemical that could inhibit the binding of E2 to BRD4, that could be a drug lead," said Howley. He and his colleagues are currently working with members of the Harvard University Department of Chemistry to identify such sm
'"/>


29-Apr-2004

Page: 1 2 3 4
Related biology news :

1. Hopkins scientists link human papillomavirus (HPV) to head and neck cancer
2. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
3. Safety of isoflavones in dietary supplements targeted by Illinois initiative
4. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
5. Evidence builds for potential new cancer drug target
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
8. Diabodies act as guided missiles targeted to mammary tumor growth
9. Anticancer drug zebularine specifically targets tumor cells
10. Study suggests cell-cycle triggers might be cancer drug targets
11. Sweet success in targeting sugar molecules to cells in living animals